Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lymphoma

• Colin Thomas,
• Sameep Thapa,
• Connor McLaughlin,
• Molly Halloran,
• Pierluigi Porcu

Affiliations

Colin Thomas

Department of Medical Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, PA, United States

Sameep Thapa

Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, United States

Connor McLaughlin

Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, United States

Molly Halloran

Department of Medical Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, PA, United States

Pierluigi Porcu

Department of Medical Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, PA, United States